¿Se necesitan más fármacos para el tratamiento de la insuficiencia cardiaca? Diferencias entre los ensayos clínicos y la práctica clínica

Nevertheless, each patient must be treated as an individual, especially as the majority have clinical characteristics (e.g., age over 70 years, preserved left ventricular function, or significant comorbid conditions) that were not (and because of methodological limitations probably never will be) represented in the controlled trials on which current guidelines are based.